Back

Seven-day holter monitoring detects more significant arrhythmias than 24-hour and 3-day monitoring

2 December 2022 (12:30 - 12:37)
Organised by:
Congress Presentation Part of: Arrhythmias 1 Diagnostic Methods ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Miss Yu Lin Lim

CardioScan Asia Pte Ltd, Singapore (Singapore)

4 More presentations in this session

Presentation thumbnail
Long-term results of zero-fluoroscopy catheter ablation in pregnant patients with arrhythmias: a 2-year follow-up study
Doctor A. Smagulova (Astana, KZ)
Abstract Slides
Presentation thumbnail
Electrocardiographic findings and incidence of new-onset atrial arrhythmia among patients with severe leptospirosis who underwent veno-venous extracorporeal membrane oxygenation
Doctor B. Quizon (Quezon, PH)
Abstract Slides
Presentation thumbnail
Comparison of adhesive single-lead cardiac ECG patch device with Holter monitoring for detecting atrial fibrillation after an acute cerebral ischemic event: An interim analysis
Doctor D. Foo (Kuching, MY)
Abstract Slides
Presentation thumbnail
Optimal international normalized ratio target in east asian populations with atrial fibrillation: systematic review and meta-analysis
Mr G. Prana Jagannatha (Denpasar, ID)
Abstract Slides

Access the full session

Session thumbnail
Arrhythmias 1

The Event

Event poster

ESC Asia 2022 with APSC & AFC

2 December 2022 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of 24-hour holter monitoring with wire-free, single lead ECG patch monitor in the diagnosis of cardiac rhythm abnormalities
5 April 2022
thumbnail
Congress Presentation
Incidental Ventricular Tachycardia: Short and Long-term Prognosis
3 September 2019
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
31 March 2025
thumbnail
Congress Presentation
Is twenty-four-seven remote patient management in heart failure necessary? Results of the telemedical emergency service used in the TIM-HF and in the TIM-HF2 trials
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources